BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30596712)

  • 1. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y
    PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling.
    Zhang J; Zhang Y; Chen Q; Qi Y; Zhang X
    Int Immunopharmacol; 2024 Mar; 130():111734. PubMed ID: 38422768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
    Koike A; Hayashi K; Fujimori K
    Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis.
    Lin JH; Liu CC; Liu CY; Hsu TW; Yeh YC; How CK; Hsu HS; Hung SC
    Redox Biol; 2024 Jun; 72():103148. PubMed ID: 38603946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased prostaglandin E2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis.
    Ogushi F; Endo T; Tani K; Asada K; Kawano T; Tada H; Maniwa K; Sone S
    Int J Exp Pathol; 1999 Feb; 80(1):41-9. PubMed ID: 10365086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of fibroblast phenotype by asbestos-induced autoantibodies.
    Pfau JC; Li S; Holland S; Sentissi JJ
    J Immunotoxicol; 2011 Jun; 8(2):159-69. PubMed ID: 21457077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis.
    Zhang F; Ayaub EA; Wang B; Puchulu-Campanella E; Li YH; Hettiarachchi SU; Lindeman SD; Luo Q; Rout S; Srinivasarao M; Cox A; Tsoyi K; Nickerson-Nutter C; Rosas IO; Low PS
    EMBO Mol Med; 2020 Aug; 12(8):e12034. PubMed ID: 32597014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts.
    Liao CH; Akazawa H; Tamagawa M; Ito K; Yasuda N; Kudo Y; Yamamoto R; Ozasa Y; Fujimoto M; Wang P; Nakauchi H; Nakaya H; Komuro I
    J Clin Invest; 2010 Jan; 120(1):242-53. PubMed ID: 20038802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice.
    Liu N; Song Y; Liu T; Wang H; Yu N; Ma H
    Clin Respir J; 2024 Jan; 18(1):e13731. PubMed ID: 38286745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis.
    Shi X; Chen Y; Liu Q; Mei X; Liu J; Tang Y; Luo R; Sun D; Ma Y; Wu W; Tu W; Zhao Y; Xu W; Ke Y; Jiang S; Huang Y; Zhang R; Wang L; Chen Y; Xia J; Pu W; Zhu H; Zuo X; Li Y; Xu J; Gao F; Wei D; Chen J; Yin W; Wang Q; Dai H; Yang L; Guo G; Cui J; Song N; Zou H; Zhao S; Distler JHW; Jin L; Wang J
    Clin Transl Med; 2022 Jan; 12(1):e711. PubMed ID: 35083881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts.
    Donovan J; Shiwen X; Norman J; Abraham D
    Fibrogenesis Tissue Repair; 2013 May; 6(1):10. PubMed ID: 23663505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model.
    Yoshida K; Chambers JK; Uchida K
    Vet Pathol; 2024 Apr; ():3009858241241793. PubMed ID: 38577818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
    Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2024 Apr; ():. PubMed ID: 38651940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immune-based tool platform for in vivo cell clearance.
    Zhang J; Tsukui T; Wu X; Brito A; Trumble JM; Caraballo JC; Allen GM; Zavala-Solorio J; Zhang C; Paw J; Lim WA; Geng J; Kutskova Y; Freund A; Kolumam G; Sheppard D; Cohen RL
    Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37311583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.
    Herrera J; Forster C; Pengo T; Montero A; Swift J; Schwartz MA; Henke CA; Bitterman PB
    JCI Insight; 2019 Jan; 4(1):. PubMed ID: 30626754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the Secrets of Idiopathic Pulmonary Fibrosis.
    Albert RK; Schwartz DA
    N Engl J Med; 2019 Jan; 380(1):94-96. PubMed ID: 30601735
    [No Abstract]   [Full Text] [Related]  

  • 17. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.
    Aran D; Looney AP; Liu L; Wu E; Fong V; Hsu A; Chak S; Naikawadi RP; Wolters PJ; Abate AR; Butte AJ; Bhattacharya M
    Nat Immunol; 2019 Feb; 20(2):163-172. PubMed ID: 30643263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
    Dutta P; Funston W; Mossop H; Ryan V; Jones R; Forbes R; Sen S; Pearson J; Griffin SM; Smith JA; Ward C; Forrest IA; Simpson AJ
    Thorax; 2019 Apr; 74(4):346-353. PubMed ID: 30610155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
    Woodcock HV; Eley JD; Guillotin D; Platé M; Nanthakumar CB; Martufi M; Peace S; Joberty G; Poeckel D; Good RB; Taylor AR; Zinn N; Redding M; Forty EJ; Hynds RE; Swanton C; Karsdal M; Maher TM; Fisher A; Bergamini G; Marshall RP; Blanchard AD; Mercer PF; Chambers RC
    Nat Commun; 2019 Jan; 10(1):6. PubMed ID: 30602778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis.
    Kropski JA; Blackwell TS
    Annu Rev Med; 2019 Jan; 70():211-224. PubMed ID: 30691371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.